Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2006

Organic colonic lesions in patients with Irritable Bowel Syndrome (IBS)

Abbasi J. Akhtar, Magda A. Shaheen, Junli Zha

Med Sci Monit 2006; 12(9): CR363-367 :: ID: 455236

Abstract

Background:To determine whether IBS patients develop organic lesions compared to those without IBS, and to determine type and frequency of these organic colonic lesions.
Material/Methods: Retrospective review of medical records of 622 IBS patients, ages 19-91 years, over fifteen years that underwent colonoscopy for new gastrointestinal symptoms during the course of their illness. Records of 642 non-IBS patients, who had colonoscopy for gastrointestinal complaints, were reviewed retrospectively as a comparison group. We abstracted and analyzed data related to demographics, history, diagnosis of IBS, and type of colonic lesions reported in the colonoscopy reports.
Results: Of the 622 patients diagnosed with IBS, the median duration of the IBS was 11 years (range =1 to 62 years). Colonoscopy findings were normal in 301 patients (48.4%) in the IBS group and 301 patients (46.9%) in the non-IBS group. Among the IBS group, the common organic colonic lesions were hemorrhoids (21.1%) polyps (20.3%) and diverticuli (19%) and angiodysplasia (11.9%). Among the non-IBS group, the common organic colonic lesions were hemorrhoids (22.6%), polyps (22.4%), diverticuli (20.6%) and angiodysplasia (12.1%). There was no difference in the prevalence of organic colonic lesions among patients with or without IBS (p>0.05). Adjusting for the demographic variables and the number of lesions, there were no differences between the groups (p>0.05).
Conclusions:IBS patients may also develop organic colonic lesions, thus colonoscopy, if indicated, should not be delayed in these patients because of the assumption that their symptoms are due to IBS alone.

Keywords: Aged, 80 and over, Colon - pathology, Colonic Diseases - epidemiology, Colonoscopy, Irritable Bowel Syndrome - surgery, Prevalence

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750